{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Cancer detection and therapy",
      "Chemotherapy",
      "Controlled drug release",
      "Magic bullet",
      "Multidrug resistance.",
      "Nanoparticles"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "24246361",
  "DateCompleted": {
    "Year": "2014",
    "Month": "07",
    "Day": "21"
  },
  "DateRevised": {
    "Year": "2013",
    "Month": "12",
    "Day": "24"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2013",
        "Month": "11",
        "Day": "15"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.tibtech.2013.10.004",
      "S0167-7799(13)00222-9"
    ],
    "Journal": {
      "ISSN": "1879-3096",
      "JournalIssue": {
        "Volume": "32",
        "Issue": "1",
        "PubDate": {
          "Year": "2014",
          "Month": "Jan"
        }
      },
      "Title": "Trends in biotechnology",
      "ISOAbbreviation": "Trends Biotechnol"
    },
    "ArticleTitle": "The potential legacy of cancer nanotechnology: cellular selection.",
    "Pagination": {
      "StartPage": "21",
      "EndPage": "31",
      "MedlinePgn": "21-31"
    },
    "Abstract": {
      "AbstractText": [
        "Overexpression of oncogenes or loss of tumour suppressors can transform a normal cell to a cancerous one, resulting in uncontrolled regulation of intracellular signalling pathways and immunity to stresses, which both pose therapeutic challenges. Conventional approaches to cancer therapy, although they are effective at killing cancer cells, may still fail due to inadequate biodistribution and unwanted side effects. Nanotechnology-based approaches provide a promising alternative, with the possibility of targeting cells at an early stage, during their transformation into cancer cells. This review considers techniques that specifically target those molecular changes, which begin in only a very small percentage of normal cells as they undergo transformation. These techniques are crucial for early-stage diagnosis and therapy."
      ],
      "CopyrightInformation": "Copyright \u00a9 2013 Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biosensors and Bioelectronics Centre, IFM, Link\u00f6ping University, Link\u00f6ping, 581 83, Sweden; Integrative Regenerative Medicine Centre, IKE, Link\u00f6ping University, Link\u00f6ping, 581 83, Sweden."
          }
        ],
        "LastName": "Patra",
        "ForeName": "Hirak K",
        "Initials": "HK"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Biosensors and Bioelectronics Centre, IFM, Link\u00f6ping University, Link\u00f6ping, 581 83, Sweden. Electronic address: anthony.turner@liu.se."
          }
        ],
        "LastName": "Turner",
        "ForeName": "Anthony P F",
        "Initials": "AP"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Research Support, Non-U.S. Gov't",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "England",
    "MedlineTA": "Trends Biotechnol",
    "NlmUniqueID": "8310903",
    "ISSNLinking": "0167-7799"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Antineoplastic Agents"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Antineoplastic Agents"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Cell Line, Tumor"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Drug Delivery Systems"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nanomedicine"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Nanoparticles"
    },
    {
      "QualifierName": [
        "diagnosis",
        "drug therapy"
      ],
      "DescriptorName": "Neoplasms"
    }
  ]
}